XML 94 R71.htm IDEA: XBRL DOCUMENT v3.22.0.1
Income Taxes - Narrative (Details) - USD ($)
$ in Millions
1 Months Ended 3 Months Ended 12 Months Ended
Dec. 29, 2019
Jan. 02, 2022
Dec. 29, 2019
Jan. 02, 2022
Jan. 03, 2021
Dec. 29, 2019
Oct. 31, 2020
Oct. 31, 2019
Dec. 30, 2018
Tax Credit Carryforward [Line Items]                  
Effective tax rate reconciliation, net increase (decrease) in tax rate, percent       (2.50%) 1.90%        
Deferred tax assets, tax basis increase of certain assets due to reorganization   $ 2,300   $ 2,300          
Increase (decrease) in deferred tax liabilities, global intangible low-taxed income (GILTI)       $ 1,700          
Tax benefits from loss on capital assets   1.30%   1.30% 1.20% 0.30%      
Income tax expense recorded related to TRAF         $ 400 $ 100      
TRAF effect on tax rate         2.60% 0.60%      
Income tax expense related to change in tax rate from TRAF         $ 300 $ 600      
Deferred tax asset recorded related to TRAF         450 900      
Deferred tax expense related to TRAF         $ 300 450      
Effective income tax rate reconciliation, deduction         1.20%        
Effective tax rate reconciliation, litigation settlement, percent     (2.10%)            
Reversal of deferred tax liability           600      
Reversal of deferred tax asset           200      
Tax Cuts And Jobs Act Of 2017, foreign tax credits, net deferred tax expense (benefit)           $ (400)      
TJCA, foreign tax credit percent 1.70%         (2.20%)      
Increase (decrease) in earnings before taxes, percent     (23.50%)            
TCJA, increase (decrease) in deferred tax asset $ 300                
Increase (decrease) in unrecognized tax benefits           $ 300      
Effective tax rate reconciliation, unrecognized tax benefits, percent           1.50%      
Unrecognized tax benefits $ 3,853 $ 3,323 $ 3,853 $ 3,323 $ 3,373 $ 3,853     $ 3,326
Unrecognized tax benefits, interest on income tax expense       44 32 50      
Unrecognized tax benefits, interest on income taxes accrued   512   $ 512 468        
State and Local Jurisdiction                  
Tax Credit Carryforward [Line Items]                  
Effective tax rate reconciliation, net increase (decrease) in tax rate, percent       2.70%          
Deferred tax assets, net   600   $ 600          
Auris Health | Purchased in-process research and development(1)                  
Tax Credit Carryforward [Line Items]                  
Impairment of intangible assets, excluding goodwill   $ 900              
Effective income tax rate reconciliation, nondeductible expense, impairment losses, percent   22.40%              
Internal Revenue Service (IRS)                  
Tax Credit Carryforward [Line Items]                  
Payment on unrecognized tax benefit liability         700        
Pending Litigation                  
Tax Credit Carryforward [Line Items]                  
Loss contingency, estimate of possible loss             $ 5,000 $ 4,000  
Consumer Health                  
Tax Credit Carryforward [Line Items]                  
Litigation expense       1,600 3,900 400      
Pharmaceutical                  
Tax Credit Carryforward [Line Items]                  
Litigation expense       600 $ 800 $ 4,300      
Talc                  
Tax Credit Carryforward [Line Items]                  
Effective income tax rate reconciliation, litigation settlement, percent         0.235        
Talc | Consumer Health                  
Tax Credit Carryforward [Line Items]                  
Litigation expense       $ 1,600 $ 4,000        
Effective income tax rate reconciliation, litigation settlement, percent       0.235          
Risperdal | Consumer Health                  
Tax Credit Carryforward [Line Items]                  
Litigation expense       $ 800          
Effective income tax rate reconciliation, litigation settlement, percent       0.164          
Opiods                  
Tax Credit Carryforward [Line Items]                  
Effective income tax rate reconciliation, litigation settlement, percent         0.214        
Opiods | Pharmaceutical                  
Tax Credit Carryforward [Line Items]                  
Litigation expense         $ 1,000